tiprankstipranks
Trending News
More News >
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Cash flow

Compare
1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Cash Flow

HK:2315's free cash flow for Q2 2025 was ¥171.71M. For the 2025 fiscal year, HK:2315's free cash flow was decreased by ¥377.38M and operating cash flow was ¥203.43M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ 211.25M¥ -76.65M¥ -303.27M¥ -365.78M¥ -225.31M
Investing Cash Flow
¥ -137.12M¥ -100.28M¥ -153.74M¥ -84.13M¥ -188.18M
Financing Cash Flow
¥ -92.03M¥ -37.82M¥ 587.20M¥ 219.44M¥ 868.44M
End Cash Position
¥ 384.46M¥ 399.61M¥ 610.88M¥ 466.44M¥ 697.29M
Free Cash Flow
¥ 174.12M¥ -203.26M¥ -543.94M¥ -564.45M¥ -531.73M
Currency in CNY

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Cash Flow